AMPA receptor inhibition alleviates inflammatory response and myocardial apoptosis after myocardial infarction by inhibiting TLR4/NF-κB signaling pathway

Myocardial infarction leads to myocardial inflammation and Apoptosis, which are crucial factors leading to heart failure and cardiovascular dysfunction, eventually resulting in death. While the inhibition of AMPA receptors mitigates inflammation and tissue Apoptosis, the effectiveness of this inhibition in the pathophysiological processes of myocardial infarction remains unclear. This study investigated the role of AMPA Receptor inhibition in myocardial infarction and elucidated the underlying mechanisms. This study established a myocardial infarction model by ligating the left anterior descending branch of the coronary artery in Sprague-Dawley rats. The findings suggested that injecting the AMPA Receptor Antagonist NBQX into myocardial infarction rats effectively alleviated cardiac inflammation, myocardial necrosis, and Apoptosis and improved their cardiac contractile function. Conversely, injecting the AMPA Receptor Agonist CX546 into infarcted rats exacerbated the symptoms and tissue damage, as reflected by histopathology. This agonist also stimulated the TLR4/NF-κB pathway, further deteriorating cardiac function. Furthermore, the investigations revealed that AMPA Receptor inhibition hindered the nuclear translocation of P65, blocking its downstream signaling pathway and attenuating tissue inflammation. In summary, this study affirmed the potential of AMPA Receptor inhibition in countering inflammation and tissue Apoptosis after myocardial infarction, making it a promising therapeutic target for mitigating myocardial infarction.

AMPA receptor; Apoptosis; Inflammation; Myocardial infarction; TLR4/NF-κB signaling pathway.